Skip to main content

Table 1 Characteristics of the total cohort also split by ISAR and CGA results

From: Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessment

 

Total (n = 547)

ISAR- (n = 229; 41.9%)

ISAR+/CGA normal (n = 145; 26.5%)

ISAR+/CGA abnormal (n = 97; 17.7%)

p-value ISAR+/CGA normal vs ISAR-

p-value ISAR+/CGA abnormal vs ISAR-

p-value ISAR+/CGA abnormal vs ISAR+/CGA normal

Age (years)

78.1 ± 6.0

77.9 ± 5.4

77.0 ± 5.9

80.5 ± 6.5

0.259

0.001

<0.001

Sex (male)

299 (54.7)

122 (53.3)

96 (66.2)

43 (44.3)

0.013

0.118

<0.001

Anemia

152 (27.8)

55 (24.0)

51 (35.2)

29 (29.9)

0.019

0.336

0.318

Chronic kidney disease

240 (43.9)

86 (37.6)

75 (51.7)

43 (44.3)

0.007

0.327

0.194

Heart failure

106 (19.4)

39 (17.0)

35 (24.1)

16 (16.5)

0.140

0.999

0.263

Coronary heart disease

213 (38.9)

90 (39.3)

51 (35.2)

45 (46.4)

0.511

0.329

0.142

Atrial fibrillation

174 (31.8)

62 (27.1)

47 (32.4)

37 (38.1)

0.293

0.050

0.412

Other cardiac arrhythmias

70 (12.8)

23 (10.0)

18 (12.4)

17 (17.5)

0.498

0.097

0.354

Valve insufficiency

196 (35.8)

78 (34.1)

53 (36.6)

39 (40.2)

0.738

0.213

0.423

Chronic obstructive pulmonary disease

69 (12.6)

25 (10.9)

17 (11.7)

15 (15.5)

0.867

0.277

0.448

Peripheral artery disease

76 (13.9)

27 (11.8)

22 (15.2)

21 (21.6)

0.348

0.040

0.237

Arterial hypertension

430 (78.6)

175 (76.4)

113 (77.9)

80 (82.5)

0.704

0.311

0.626

Diabetes

171 (31.3)

71 (31.0)

45 (31.0)

33 (34.0)

0.999

0.606

0.676

Hyperlipoproteinemia

269 (49.2)

96 (41.9)

79 (54.5)

55 (56.7)

0.025

0.011

0.694

Nicotine abuse

82 (15.0)

34 (14.8)

25 (17.2)

11 (11.3)

0.561

0.484

0.202

Obesity

116 (21.2)

46 (20.1)

29 (20.0)

23 (23.7)

0.999

0.463

0.427

History of myocardial infarction

56 (10.2)

23 (10.0)

9 (6.2)

13 (13.4)

0.255

0.443

0.073

History of pulmonary embolism

11 (2.0)

2 (0.9)

4 (2.8)

3 (3.1)

0.378

0.070

0.447

History of stroke

56 (10.2)

14 (6.1)

16 (11.0)

15 (15.5)

0.116

0.006

0.255

History of thrombosis

49 (9.0)

19 (8.3)

10 (6.9)

12 (12.4)

0.695

0.306

0.179

Hyperthyroidism

24 (4.4)

15 (6.6)

1 (0.7)

5 (5.2)

0.007

0.802

0.042

Hypothyroidism

84 (15.4)

30 (13.1)

30 (20.7)

11 (11.3)

0.081

0.859

0.118

Dementia

37 (6.8)

4 (1.7)

9 (6.2)

16 (16.5)

0.067

<0.001

0.005

Alcohol abuse

19 (3.5)

6 (2.6)

7 (4.8)

2 (2.1)

0.261

0.999

0.317

Depression

30 (5.5)

9 (3.9)

5 (3.4)

7 (7.2)

0.999

0.265

0.236

Anxiety disorder

2 (0.4)

1 (0.4)

0 (0.0)

0 (0.0)

0.999

0.999

0.999

Parkinson’s disease

6 (1.1)

3 (1.3)

2 (1.4)

0 (0.0)

0.999

0.557

0.515

Polyneuropathy

40 (7.3)

13 (5.7)

10 (6.9)

14 (14.4)

0.825

0.009

0.028

Cancer

215 (39.3)

89 (38.9)

73 (50.3)

21 (21.6)

0.041

0.003

<0.001

Cataract

33 (6.0)

8 (3.5)

13 (9.0)

6 (6.2)

0.036

0.371

0.472

Presbycusis

21 (3.8)

8 (3.5)

4 (2.8)

7 (7.2)

0.773

0.161

0.128

Anal incontinence

3 (0.5)

1 (0.4)

2 (1.4)

0 (0.0)

0.562

0.999

0.515

Urinary incontinence

4 (0.7)

1 (0.4)

0 (0.0)

2 (2.1)

0.999

0.218

0.165

Pressure ulcers

24 (4.4)

1 (0.4)

4 (2.8)

14 (14.4)

0.075

<0.001

0.002

Rheumatism

24 (4.4)

11 (4.8)

5 (3.4)

4 (4.1)

0.609

0.999

0.999

  1. CGA, comprehensive geriatric assessment; ISAR, Identification of Seniors at Risk; ISAR+, positive ISAR screening (score ≥ 2); ISAR-, negative ISAR screening (score < 2); CGA abnormal, impairment of ADL plus another domain of the CGA. In 318 ISAR+ patients, 242 CGAs were performed (76 missing due to transfer, discharge, foreign-language or incompliance of patients). Boldface values were significant at p <=0.05